COMPANY

Brenig Therapeutics

Keywords: small molecule neurology neurodegenerative diseases Parkinson's disease

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗

Raise Series A · $65M · announced Jul 23, 2024 Company release ↗
Source quote
- Jul 23, 2024 · Company release ↗
  “Brenig Therapeutics Announces $65 Million Series A Financing to Advance Leading Pre-Clinical Parkinson’s Disease Pipeline”

Raises announced in these releases: $65M disclosed.

From the company’s own releases; this list is partial. All raises and deals